Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '3-AMINO-1,2,4-BENZOTRIAZINE 1,4-DIOXIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 16 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Denny, WA; Wilson, WR
      Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Patterson, LH; Taiwo, FA
      Electron paramagnetic resonance spectrometry evidence for bioreduction of tirapazamine to oxidising free radicals under anaerobic conditions

      BIOCHEMICAL PHARMACOLOGY
    3. Suzuki, H; Kawakami, T
      Straightforward synthesis of some 2- or 3-substituted naphtho- and quinolino[1,2,4]triazines via the cyclocondensation of nitronaphthalenes and nitroquinolines with guanidine base

      JOURNAL OF ORGANIC CHEMISTRY
    4. Garner, AP; Paine, MJI; Rodriguez-Crespo, I; Chinje, EC; De Montellano, PO; Stratford, IJ; Tew, DG; Wolf, CR
      Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents

      CANCER RESEARCH
    5. Kelson, AB; McNamara, JP; Pandey, A; Ryan, KJ; Dorie, MJ; McAfee, PA; Menke, DR; Brown, JM; Tracy, M
      1,2,4-Benzotriazine 1,4-dioxides. An important class of hypoxic cytotoxinswith antitumor activity

      ANTI-CANCER DRUG DESIGN
    6. SENAN S; RAMPLING R; GRAHAM MA; WILSON P; ROBIN H; ECKARDT N; LAWSON N; MCDONALD A; VONROEMELING R; WORKMAN P; KAYE SB
      PHASE-I AND PHARMACOKINETIC STUDY OF TIRAPAZAMINE (SR-4233) ADMINISTERED EVERY 3 WEEKS

      Clinical cancer research
    7. AGHAJANIAN C; BROWN C; OFLAHERTY C; FLEISCHAUER A; CURTIN J; VONROEMELING R; SPRIGGS DR
      PHASE-I STUDY OF TIRAPAZAMINE AND CISPLATIN IN PATIENTS WITH RECURRENT CERVICAL-CANCER

      Gynecologic oncology
    8. HOLDEN SA; TEICHER BA
      COMBINATIONS OF TNP-470 OR SR-4233 WITH ANTITUMOR ALKYLATING-AGENTS IN EMT-6 SPHEROIDS AND MONOLAYERS

      International journal of oncology
    9. LIANG XZ; PALSMEIER RK; LUNTE CE
      DUAL-ELECTRODE AMPEROMETRIC DETECTION FOR THE DETERMINATION OF SR4233AND ITS METABOLITES WITH MICROBORE LIQUID-CHROMATOGRAPHY

      Journal of pharmaceutical and biomedical analysis
    10. PATTERSON AV; BARHAM HM; CHINJE EC; ADAMS GE; HARRIS AL; STRATFORD IJ
      IMPORTANCE OF P450 REDUCTASE-ACTIVITY IN DETERMINING SENSITIVITY OF BREAST-TUMOR CELLS TO THE BIOREDUCTIVE DRUG, TIRAPAZAMINE (SR-4233)

      British Journal of Cancer
    11. KHAN S; OBRIEN PJ
      MOLECULAR MECHANISMS OF TIRAPAZAMINE (SR-4233, WIN-59075)-INDUCED HEPATOCYTE TOXICITY UNDER LOW-OXYGEN CONCENTRATIONS

      British Journal of Cancer
    12. TUTTLE SW; HAZARD L; KOCH CJ; MITCHELL JB; COLEMAN CN; BIAGLOW JE
      BIOREDUCTIVE METABOLISM OF SR-4233 (WIN-59075) BY WHOLE-CELL SUSPENSIONS UNDER AEROBIC AND HYPOXIC CONDITIONS - ROLE OF THE PENTOSE CYCLE AND IMPLICATIONS FOR THE MECHANISM OF CYTOTOXICITY OBSERVED IN AIR

      International journal of radiation oncology, biology, physics
    13. PATTERSON AV; ROBERTSON N; HOULBROOK S; STEPHENS MA; ADAMS GE; HARRIS AL; STRATFORD IJ; CARMICHAEL J
      THE ROLE OF DT-DIAPHORASE IN DETERMINING THE SENSITIVITY OF HUMAN TUMOR-CELLS TO TIRAPAZAMINE (SR-4233)

      International journal of radiation oncology, biology, physics
    14. ARA G; COLEMAN CN; TEICHER BA
      SR-4233 (TIRAPAZAMINE) ACTS AS AN UNCOUPLER OF OXIDATIVE-PHOSPHORYLATION IN HUMAN MCF-7 BREAST-CARCINOMA CELLS

      Cancer letters
    15. WALTON MI; WORKMAN P
      PHARMACOKINETICS AND BIOREDUCTIVE METABOLISM OF THE NOVEL BENZOTRIAZINE DI-N-OXIDE HYPOXIC CELL CYTOTOXIN TIRAPAZAMINE (WIN-59075 - SR-4233- NSC-130181) IN MICE

      The Journal of pharmacology and experimental therapeutics
    16. SILVA JM; OBRIEN PJ
      MOLECULAR MECHANISMS OF SR 4233-INDUCED HEPATOCYTE TOXICITY UNDER AEROBIC VERSUS HYPOXIC CONDITIONS

      British Journal of Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 00:30:31